Eribulin in Metastatic Breast Cancer: Actual Clinical Practice

Eribulin in Metastatic Breast Cancer: Actual Clinical Practice

Breast cancer is the most common cancer in women, both in the Russian Federation and in the United States. Eribulin is a new microtubule inhibitor, used in the USA, Europe and other countries around the world to treat patients with advanced or metastatic breast cancer, resistant to other lines of th...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, V. E. Askarov
Format: Article
Language:English
Published: Bashkir State Medical University 2023-04-01
Series:Креативная хирургия и онкология
Subjects:
breast cancer
metastases
eribulin
microtubule inhibitor
anticancer agents
chemotherapy
halichondrin
Online Access:https://www.surgonco.ru/jour/article/view/774
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.surgonco.ru/jour/article/view/774

Similar Items